Application of Ultralow Doses of Antibodies to Interferon-[gamma] in Complex Therapy of Bacterial Infections and Prophylaxis of Bacterial Complications

Comparative placebo-controlled clinical trials on the efficiency and safety of ultralow doses of antibodies to human IFN-γ (anaferon pediatric formulation and anaferon) and prophylaxis of bacterial complication showed that administration of these preparations in complex therapy of bacterial infectio...

Full description

Saved in:
Bibliographic Details
Published inBulletin of experimental biology and medicine Vol. 148; no. 2; p. 295
Main Authors Tarasov, S A, Kachanova, M V, Zhavbert, E S, Dugina, Yu L, Epshtein, O I, Sergeeva, S A
Format Journal Article
LanguageEnglish
Published New York Springer Nature B.V 01.08.2009
Online AccessGet full text

Cover

More Information
Summary:Comparative placebo-controlled clinical trials on the efficiency and safety of ultralow doses of antibodies to human IFN-γ (anaferon pediatric formulation and anaferon) and prophylaxis of bacterial complication showed that administration of these preparations in complex therapy of bacterial infection reduced the incidence of bacterial complications of viral infections and considerably decreased the duration of the main clinical symptoms of the disease.
ISSN:0007-4888
1573-8221
DOI:10.1007/s10517-009-0699-4